drug fraud http://kplu.org en Exploring the Gates Foundation's connection to the Glaxo scandal http://kplu.org/post/exploring-gates-foundations-connection-glaxo-scandal <p>In a &quot;landmark&quot; legal case, the pharmaceutical giant GlaxoSmithKline pled guilty last week to engaging in <a href="http://bottomline.msnbc.msn.com/_news/2012/07/02/12525279-glaxosmithkline-settles-fraud-case-for-3-billion?lite" target="_blank">fraudulent, criminal behavior</a> which included covering up adverse drug side-effects, promoting ineffective therapies and hiding unfavorable data &mdash; and will <a href="http://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html?pagewanted=all://" target="_blank">pay a record $3 billion in fines</a>.</p><p>An aspect of the story that seems to be underreported is that one high-profile Glaxo executive alleged to have engaged in misbehavior is Tachi Yamada, former head of global health for the Bill &amp; Melinda Gates Foundation who was before that head of research and development for GSK.</p><p><a href="http://humanosphere.kplu.org/2012/07/the-gates-foundation-connection-to-the-glaxo-drug-fraud-scandal/"><strong>Read more on Humanosphere.</strong></a></p><p> Thu, 05 Jul 2012 19:05:23 +0000 Tom Paulson 5510 at http://kplu.org Exploring the Gates Foundation's connection to the Glaxo scandal